Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom van Wezel

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 18, 2025
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluidBerit M H van Linder, Dieta Brandsma, Els Verhoeven, et al.
The Oncologist|July 12, 2021
Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II StudyF J Sherida H Woei-A-Jin, Nir I Weijl, Mark C Burgmans, et al.
Plos One|November 19, 2013
The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumorsAshwin A Dihal, Arnoud Boot, Eddy H van Roon, et al.
The Journal of Clinical Endocrinology and Metabolism|September 28, 2018
Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 SyndromeKarin van der Tuin, Leanne de Kock, Eveline J Kamping, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to CrizotinibChe-Jui Lee, Patrick Schöffski, Elodie Modave, et al.
Plos One|March 17, 2011
Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCRRonald van Eijk, Jappe Licht, Melanie Schrumpf, et al.
Cancer Research|July 16, 2009
Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatmentYvonne M Schrage, Inge H Briaire-de Bruijn, Noel F C C de Miranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapyYi-Xiang Zhang, Jolieke G van Oosterwijk, Ewa Sicinska, et al.
Hereditary Cancer in Clinical Practice|December 31, 2013
The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patientsBente A Talseth-Palmer, Juul T Wijnen, Eva K Andreassen, et al.
Familial Cancer|April 17, 2008
Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomasMarjo van Puijenbroek, Anneke Middeldorp, Carli M J Tops, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|September 18, 2025
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluidBerit M H van Linder, Dieta Brandsma, Els Verhoeven, et al.
The Oncologist|July 12, 2021
Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II StudyF J Sherida H Woei-A-Jin, Nir I Weijl, Mark C Burgmans, et al.
Plos One|November 19, 2013
The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumorsAshwin A Dihal, Arnoud Boot, Eddy H van Roon, et al.
The Journal of Clinical Endocrinology and Metabolism|September 28, 2018
Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 SyndromeKarin van der Tuin, Leanne de Kock, Eveline J Kamping, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to CrizotinibChe-Jui Lee, Patrick Schöffski, Elodie Modave, et al.
Plos One|March 17, 2011
Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCRRonald van Eijk, Jappe Licht, Melanie Schrumpf, et al.
Cancer Research|July 16, 2009
Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatmentYvonne M Schrage, Inge H Briaire-de Bruijn, Noel F C C de Miranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapyYi-Xiang Zhang, Jolieke G van Oosterwijk, Ewa Sicinska, et al.
Hereditary Cancer in Clinical Practice|December 31, 2013
The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patientsBente A Talseth-Palmer, Juul T Wijnen, Eva K Andreassen, et al.
Familial Cancer|April 17, 2008
Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomasMarjo van Puijenbroek, Anneke Middeldorp, Carli M J Tops, et al.
Pageof 22